Member Info for Howzaty

Yes, percentages of 100s of percents look worrying. At this stage I simply focus on whether share prices of 200p, 500p and 2000p ate still possible and dont look at portfolio value. Of course all are possible in the short to medium term, provided the Avacta board get their act together.

Got it. Looks odd.

Can you point to the Affimer reference please. Can't seem to find it.

Cancelling the LFT would be a stupid move in my opinion and AS is definitely not stupid. So, just a questioh of when the best LFT in the world is able to be sold.

A key element of getting Affidx sorted is "driving the cost out of it". Get that right and sort the antibody issue preferably with a suitable Affimer and we will be quids in. Rather they do the complete job than half a job.

I can relate to that, I hope you've managed to avoid the rash Ive developed! But lets hope its upwards and onwards.

Its nice to think that tomorrow ,or in any event shortly, we may find that a takeover offer is on the table for 10 Billion or so. Would be a weight off my mind anyhoo.

Liked this in the Affimer Scaffold document which isnt something thats yet been confirmed formally to my knowledge and should add a Billion or so the the Market Cap ...

"Does not induce immune response or toxicity in humans • stable under a wide range of salt concentrations, pH and temperatures • can be immobilised on solid supports."

Say what you like but AS and Avacta have been victims of circumstance, in part (in my opinion) bribery and corruption. But he hit the nail on the head with we will sell all we can make, turns out we couldnt make that many. But on the AffiDX front the foundations of a good business for sale or otherwise have been put in place in double quick time. Lets hope new products are in the offing, Covid test was just the beginning. Partnerships are looking solid, Affimers could replace 100 Billion worth of Antibodies or so. Still a great investment case. This is a very long way from being a basket case, will be a long wait to July but the best course is to check the share price less often. Goodluck to those left standing, Im in until the buy out or 2500p which ever comes sooner, but not loosening my grip until then. Keep smiling all.

There is a unique feature about Prodox, to wit if phase 1a outturns positive data there is a real prospect that Prodox would take, without any competition, the whole 75Billion Dollar chemo market for the target drugs. Not a percentage of but the whole market. Good to buy, bad to miss out on!

Wyndrum, just saying you have progressed from my ignore-list to read with interest. Not sure whats brought about the change but thanks and keep up the good work.

Well if Big Pharma wasnt looking before they will be looking now and there may be a touch of squeeky bum developing at the thought of their multi billion dollar markets being taken overnight. I hope the Avacta boardroom is looking tidy because there will be a few important visitors over the next weeks. Also, lets not forget that given this first dose escallation its likely that the safety margin for delivery of Dox has already been improved to a degree so Avacta already has a better version of Dox on its hands. The only way is up baby and perhaps a cheeky bid in the not too distant future, so hold tight all and congratulations all long term holders your patience has been rewarded, you bought into a possible 100 bagger!

Ha ha "not man the life boats" good to have laugh here!

Regarding selection for a trial, in my experience a consultant will approach a often very sick patient and ask if they would like to participate in a trial which may help them and other cancer sufferers in the future. There are many altruistic folk who participate for the benefit of others.

Goody, I hope and believe you are right. But can do without this experience again, looking at a share price every morning and throughout the day does no one any good and I have the rash to prove it. Moving on, the tortoise is finally about to switch on its turbo charger so hold tight good times are coming. GLA Long Time Sufferers.

Nah, you don't put a transformative RNS out on a Friday ...

Guess I''ve been cynical for years but the events of this pandemic has brought home to me how corrupt the whole sh** sh** really is. You want a certain result so you set the ct value where you need to to get that result. Never mind that the medical concensus that ct < 25 is barely acceptable they set it at ct 20. Not incompetence but corruption and lies. Not bl**dy good enough. Avacta plays with a straight bat using up to ct « 30 and they get pushed aside. Not bl**dy good enough.

Well done on the FOI request. What has been revealed is criminal, in my opinion. Its fraud in that they accepted payment for a service and essentially failed to provide it, seemingly they had no intention of providing it. This should be dynamite in the right hands because the consequences of Government action has, again in my opinion, inflicted reputational damage. As was said at the time "if your own Government won't buy your LFT why should you expect other nations to". Its either corruption or stupidity on a monumental scale, if Avacta is aware of this I hope they instruct their legal team to take action, ODX as well. Unbelievable.

Interesting interpretation of what 1a means and not aligned with my own thinking. If the data gathered indicates that the dox has been largely contained within the tumour and that the rest of the body has not suffered the usual toxic effects, which I know all too well from family illness, then Precision works. Dox works so no question mark there. The only question then becomes how much dox can you/ should you load into the tumour. So in my mind there is a big jump in the share price after successful phase 1a and lots of i terest from big pharma. Perhaps Ophidian, or others, can set me right if Im off at a tangent.

Strange situation isnt it. If I'd had cash on the side I would have bought by now! We know there is no bad news, we know the last thing stated by AS was "very pleased" we know 3 days of meet and great planned, we know we have a group of world class oncologists standing with Avacta, we know the US trial was accepted, we know the next candidate Precision Drug has been selected. What baffles me is how anyone can think an update could happen saying anything but AVA 6000 phase 1a was a success. Perhaps I'm off my rocker!